Stoke Therapeutics Inc (STOK): STOK: "Stoke Therapeutics (NASDAQ:STOK)...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	171
Posts	10039
Boards Moderated	3
Alias Born	06/20/2022

Invest-in-America

Re: None

Monday, 03/25/2024 8:53:50 PM

Monday, March 25, 2024 8:53:50 PM

STOK: "Stoke Therapeutics (NASDAQ:STOK) stock shot up 70% in post-market trading Monday after the company reported positive results from studies for its drug STK-001 in the treatment of children and adolescents with Dravet syndrome, a genetic form of epilepsy. The biotech company said data from two Phase 1/2a studies and two open label extension, or OLE, studies showed “clinically meaningful effects” that included “substantial and durable reductions in convulsive seizure frequency."
https://seekingalpha.com/news/4083468-stoke-stock-soars-post-market-on-epilepsy-drug-data

Dravet Syndrome is an extremely RARE disease in the USA. And the above news does NOT specify nor suggest that STOK's (potential) treatment for Dravet Syndrome will or might have any applications for treatment of EPILEPSY at all. (Be very CAREFUL about news like the above.)